KBC Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
11,324
+712
| +7% | +$156K | 0.01% | 549 |
|
|
2025
Q1 | $2.38M | Buy |
10,612
+632
| +6% | +$142K | 0.01% | 564 |
|
|
2024
Q4 | $3.27M | Buy |
9,980
+42
| +0.4% | +$13.8K | 0.01% | 578 |
|
|
2024
Q3 | $2.98M | Sell |
9,938
-7,441
| -43% | -$2.23M | 0.01% | 546 |
|
|
2024
Q2 | $5.72M | Sell |
17,379
-1,964
| -10% | -$647K | 0.02% | 407 |
|
|
2024
Q1 | $7.65M | Sell |
19,343
-84,221
| -81% | -$33.3M | 0.02% | 376 |
|
|
2023
Q4 | $36.5M | Sell |
103,564
-8,006
| -7% | -$2.82M | 0.13% | 173 |
|
|
2023
Q3 | $41.9M | Buy |
111,570
+5,267
| +5% | +$1.98M | 0.17% | 130 |
|
|
2023
Q2 | $40.7M | Buy |
106,303
+60,230
| +131% | +$23M | 0.17% | 136 |
|
|
2023
Q1 | $16M | Buy |
46,073
+3,315
| +8% | +$1.15M | 0.07% | 275 |
|
|
2022
Q4 | $10.1M | Sell |
42,758
-22,042
| -34% | -$5.19M | 0.05% | 317 |
|
|
2022
Q3 | $15.9M | Sell |
64,800
-2,085
| -3% | -$513K | 0.08% | 240 |
|
|
2022
Q2 | $20.2M | Sell |
66,885
-963
| -1% | -$291K | 0.1% | 223 |
|
|
2022
Q1 | $27.9M | Sell |
67,848
-40,227
| -37% | -$16.5M | 0.11% | 202 |
|
|
2021
Q4 | $50.7M | Sell |
108,075
-1,678
| -2% | -$787K | 0.17% | 147 |
|
|
2021
Q3 | $46.6M | Sell |
109,753
-143,165
| -57% | -$60.8M | 0.17% | 141 |
|
|
2021
Q2 | $90.8M | Sell |
252,918
-10,466
| -4% | -$3.76M | 0.16% | 143 |
|
|
2021
Q1 | $74.2M | Buy |
263,384
+65,336
| +33% | +$18.4M | 0.15% | 170 |
|
|
2020
Q4 | $309M | Sell |
198,048
-111,638
| -36% | -$174M | 0.13% | 185 |
|
|
2020
Q3 | $85.1M | Buy |
309,686
+87,248
| +39% | +$24M | 0.25% | 91 |
|
|
2020
Q2 | $50.5M | Buy |
222,438
+170,765
| +330% | +$38.8M | 0.17% | 131 |
|
|
2020
Q1 | $7.87M | Buy |
51,673
+46,391
| +878% | +$7.06M | 0.07% | 284 |
|
|
2019
Q4 | $794K | Buy |
+5,282
| New | +$794K | 0.01% | 965 |
|